Cargando…
Characterization of genetic alterations in brain metastases from non‐small cell lung cancer
Brain metastasis (BM) is the primary contributor to mortality in non‐small cell lung cancer (NSCLC) patients. Although the findings of NSCLC genetic sequencing studies suggest the potential for personalizing therapeutic approaches, the genetic profiles and underlying mechanisms of BM progression rem...
Autores principales: | Liao, Li, Ji, Xiaoyu, Ge, Mengxi, Zhan, Qiong, Huang, Ruofan, Liang, Xiaohua, Zhou, Xinli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6120240/ https://www.ncbi.nlm.nih.gov/pubmed/30186753 http://dx.doi.org/10.1002/2211-5463.12501 |
Ejemplares similares
-
PSPH Mediates the Metastasis and Proliferation of Non-small Cell Lung Cancer through MAPK Signaling Pathways
por: Liao, Li, et al.
Publicado: (2019) -
Different next-generation sequencing pipelines based detection of tumor DNA in cerebrospinal fluid of lung adenocarcinoma cancer patients with leptomeningeal metastases
por: Ge, Mengxi, et al.
Publicado: (2019) -
Upregulation of phosphoserine phosphatase contributes to tumor progression and predicts poor prognosis in non‐small cell lung cancer patients
por: Liao, Li, et al.
Publicado: (2019) -
Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram
por: Ji, Xiaoyu, et al.
Publicado: (2017) -
Improved Survival With Surgical Treatment of Primary Lung Lesions in Non-Small Cell Lung Cancer With Brain Metastases: A Propensity‐Matched Analysis of Surveillance, Epidemiology, and End Results Database
por: Wang, Qing, et al.
Publicado: (2022)